Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$2.25 - $4.67 $125,176 - $259,810
-55,634 Reduced 58.98%
38,700 $96,000
Q3 2022

Nov 14, 2022

BUY
$2.66 - $5.37 $250,928 - $506,573
94,334 New
94,334 $397,000
Q1 2022

May 16, 2022

SELL
$4.63 - $9.94 $133,807 - $287,266
-28,900 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$8.35 - $12.6 $181,195 - $273,420
-21,700 Reduced 42.89%
28,900 $264,000
Q3 2021

Nov 16, 2021

BUY
$10.13 - $15.0 $85,092 - $126,000
8,400 Added 19.91%
50,600 $541,000
Q2 2021

Aug 16, 2021

BUY
$13.27 - $18.48 $559,994 - $779,856
42,200 New
42,200 $655,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.